According to AstraZeneca's latest financial reports the company's current earnings are ยฃ54.07 Billion. , an increase over its 2023 earnings that were of ยฃ6.60 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | ยฃ8.07 B | 22.28% |
2023 | ยฃ6.60 B | 122.77% |
2022 | ยฃ2.96 B | 278.83% |
2021 | ยฃ0.78 B | -80.51% |
2020 | ยฃ4.01 B | 75.86% |
2019 | ยฃ2.28 B | -12.18% |
2018 | ยฃ2.60 B | -6.54% |
2017 | ยฃ2.78 B | -26.94% |
2016 | ยฃ3.80 B | 19.74% |
2015 | ยฃ3.18 B | 86.05% |
2014 | ยฃ1.70 B | -41.35% |
2013 | ยฃ2.91 B | -54.57% |
2012 | ยฃ6.41 B | -37.9% |
2011 | ยฃ10.33 B | 11.18% |
2010 | ยฃ9.29 B | 0% |
2009 | ยฃ9.29 B | 31.29% |
2008 | ยฃ7.08 B | 12.97% |
2007 | ยฃ6.26 B | 0.97% |
2006 | ยฃ6.20 B | 23.29% |
2005 | ยฃ5.03 B | -2526.12% |
2004 | -ยฃ0.21 Billion | -106.52% |
2003 | ยฃ3.18 B | 3.54% |
2002 | ยฃ3.07 B | -33.34% |
2001 | ยฃ4.61 B | 49.57% |
2000 | ยฃ3.08 B | |
1997 | ยฃ1.74 B | -43.89% |
1996 | ยฃ3.11 B | |
1994 | ยฃ1.08 B | 22.61% |
1993 | ยฃ0.88 B |